Status:
COMPLETED
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Lead Sponsor:
Yonsei University
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
Phase:
NA
Brief Summary
Recently, intravitreal bevacizumab (Avastin) injection has gained popularity as a potential treatment of intraocular neovascularization (CNV) associated with age related macular degeneration and diabe...
Eligibility Criteria
Inclusion
- Tractional retinal detachment recently involving the macula with fibrovascular membrane due to proliferative diabetic retinopathy
- Severe fibrovascular proliferation progressing after appropriate panretinal photocoagulation
Exclusion
- Uncontrolled systemic hypertension
- Recent history of myocardiac infarction within 6 months
- Recent history of cerebrovascular accident within 6 months
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00423059
Start Date
December 1 2006
End Date
March 1 2007
Last Update
March 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Yonsei University College of Medicine
Seoul, South Korea, 120-752